Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Christopher Kjaer Cullum"'
Autor:
Frederik Thal Jantzen, Basit Ali Chaudhry, Samaira Younis, Ina Nørgaard, Christopher Kjaer Cullum, Thien Phu Do, Dagmar Beier, Faisal Mohammad Amin
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Physical activity can worsen migraine, leading to reduced activity levels in adults with chronic migraine. This study investigated the change in average steps per day, as a surrogate marker of physical activity, in adults with chronic migrai
Externí odkaz:
https://doaj.org/article/502c38b6f08d4a6b9a82994472663b2e
Autor:
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, Rune Häckert Christensen, Haidar Muhsen Al-Khazali, Faisal Mohammad Amin, Messoud Ashina, on behalf of the REFORM Investigators
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background Erenumab has demonstrated effectiveness for prevention of migraine attacks, but the treatment is costly, and a considerable proportion of patients do not respond to it. The Registry for Migraine study (REFORM) was initiated to dis
Externí odkaz:
https://doaj.org/article/978ea8b2248748bda37125c6ed1b7d70
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundFollowing the promising pre-marketing placebo-controlled randomized clinical trials of fremanezumab, post-marketing studies are necessary to verify efficacy and tolerability in various real-world settings. The present study assessed real-wo
Externí odkaz:
https://doaj.org/article/9566461199484b8a829f1c301604ad43
Autor:
Christopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, Lars Bendtsen, Sarah Sonja Hugger, Afrim Iljazi, Julia Gusatovic, Josefin Snellman, Cristina Lopez-Lopez, Håkan Ashina, Faisal Mohammad Amin
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Clinical trials have shown that erenumab is effective and well-tolerated for the preventive treatment of chronic migraine. To extend the results from clinical trials, we assessed the real-world efficacy and safety of erenumab in p
Externí odkaz:
https://doaj.org/article/bc1e00ecf6124af0b6ccf3440c24f7de
Autor:
Lucas Rundblad, Christopher Kjaer Cullum, Simona Sacco, Raquel Gil-Gouveia, Derya Uludüz, Thien Phu Do, Faisal Mohammad Amin
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
IntroductionAccessibility of treatment with monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) signaling pathway is impeded by regulatory restrictions. Affected individuals may seek out other services including non-pharmacolog
Externí odkaz:
https://doaj.org/article/fdd99beaa91a45eeb3a7acb6091ff9d2
Autor:
Kristoffer Larsen Norheim, Michael Kjaer, Anders Karlsen, Jesper L. Andersen, Christopher Kjaer Cullum
Publikováno v:
Medicine & Science in Sports & Exercise. 49:1079-1085
Purpose: Aging is associated with a gradual loss of muscle mass, which some have suggested to be accelerated by short periods of muscle disuse due to medical illness. We investigated the effect of hospitalization on skeletal muscle mass in acutely il
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf77058a0dc93c5efaf8ad379ab911a7
https://doi.org/10.1249/mss.0000000000001221
https://doi.org/10.1249/mss.0000000000001221